Rezultati pretrage - S. Ehrenforth

  • Prikaz rezultata 1 – 5 od 5
Detaljiziraj rezultate
  1. 1
    Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia

    Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia od Ralf Junker, Hans-Georg Koch, K. Auberger, N. Münchow, S. Ehrenforth, Ulrike Nowak‐Göttl

    Izdano 1999
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  2. 2
    Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

    Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa od Steven R. Lentz, S. Ehrenforth, Faraizah Abdul Karim, Tadashi Matsushita, Karin Weldingh, Jerzy Windyga, Johnny Mahlangu

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  3. 3
    Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa

    Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa od Lentz, S R, Ehrenforth, S, Abdul Karim, F, Matsushita, T, Weldingh, K N, Windyga, J, Mahlangu, J N, For the Adept™2 Investigators

    Izdano 2014
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  4. 4
    Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial

    Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial od Erich Vinícius De Paula, Kaan Kavaklı, Johnny Mahlangu, Yasmin Ayob, Steven R. Lentz, Massimo Morfini, László Nemes, Silva Zupančić Šalek, Midori Shima, Jerzy Windyga, S. Ehrenforth, Ampaiwan Chuansumrit

    Izdano 2011
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:
  5. 5
    Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity

    Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity od Johnny Mahlangu, Karin Weldingh, Steven R. Lentz, Shipra Kaicker, Faraizah Abdul Karim, Tadashi Matsushita, Michael Recht, Waldemar Tomczak, Jerzy Windyga, S. Ehrenforth, Karin Knobe, Ansgar Weltermann, Erich Vinícius De Paula, M. Cerqueira, Silva Zupančić‐Šalek, Όλγα Κατσαρού, Marina Economou, László Nemes, Z Boda, Elena Santagostino, Giuseppe Tagariello, Hideji Hanabusa, Katsuyuki Fukutake, Midori Shima, M. Şerban, Ivo Elezović, Aleksandar Savić, Ming Shen, Ampaiwan Chuansumrit, Pantep Angchaisuksiri, Kaan Kavaklı, İlgen Şaşmaz, Bella Madan, Paul Giangrande, Christine L. Kempton, Guy Young, Doris Quon, Afshin Ameri, Philip Kuriakose, Dana Obzut, Michael Wang, I. P. Yánez Ortiz

    Izdano 2015
    Preuzmi cijeli tekst Preuzmi cijeli tekst
    Artigo
    Spremi u popis
    Spremljeno u:

Alati za pretragu: